Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics Statistics

Total Valuation

TCRT has a market cap or net worth of $6.02 million. The enterprise value is $3.14 million.

Market Cap	6.02M
Enterprise Value	3.14M

Important Dates

The next estimated earnings date is Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TCRT has 2.21 million shares outstanding. The number of shares has increased by 1.20% in one year.

Current Share Class	2.21M
Shares Outstanding	2.21M
Shares Change (YoY)	+1.20%
Shares Change (QoQ)	+4.69%
Owned by Insiders (%)	13.27%
Owned by Institutions (%)	7.94%
Float	1.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1,003.60
Forward PS	n/a
PB Ratio	1.54
P/TBV Ratio	1.64
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	523.77
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.48

Current Ratio	3.48
Quick Ratio	2.68
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -107.45% and return on invested capital (ROIC) is -67.90%.

Return on Equity (ROE)	-107.45%
Return on Assets (ROA)	-53.61%
Return on Invested Capital (ROIC)	-67.90%
Return on Capital Employed (ROCE)	-110.27%
Revenue Per Employee	$6,000
Profits Per Employee	-$3.99M
Employee Count	1
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.38% in the last 52 weeks. The beta is -0.85, so TCRT's price volatility has been lower than the market average.

Beta (5Y)	-0.85
52-Week Price Change	+32.38%
50-Day Moving Average	2.62
200-Day Moving Average	2.60
Relative Strength Index (RSI)	46.87
Average Volume (20 Days)	1,286,036

Short Selling Information

The latest short interest is 108,944, so 4.94% of the outstanding shares have been sold short.

Short Interest	108,944
Short Previous Month	60,825
Short % of Shares Out	4.94%
Short % of Float	5.69%
Short Ratio (days to cover)	0.10

Income Statement

In the last 12 months, TCRT had revenue of $6,000 and -$3.99 million in losses. Loss per share was -$2.46.

Revenue	6,000
Gross Profit	-581,000
Operating Income	-4.04M
Pretax Income	-3.99M
Net Income	-3.99M
EBITDA	-4.04M
EBIT	-4.04M
Loss Per Share	-$2.46

Balance Sheet

The company has $2.88 million in cash and n/a in debt, giving a net cash position of $2.88 million or $1.31 per share.

Cash & Cash Equivalents	2.88M
Total Debt	n/a
Net Cash	2.88M
Net Cash Per Share	$1.31
Equity (Book Value)	3.66M
Book Value Per Share	1.76
Working Capital	2.66M

Cash Flow

Operating Cash Flow	-2.85M
Capital Expenditures	n/a
Free Cash Flow	-2.85M
FCF Per Share	-$1.29

Margins

Gross Margin	n/a
Operating Margin	-67,283.33%
Pretax Margin	-66,550.00%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TCRT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.20%
Shareholder Yield	-1.20%
Earnings Yield	-66.31%
FCF Yield	-47.26%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 18, 2024. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 18, 2024
Split Type	Reverse
Split Ratio	1:10

Scores

TCRT has an Altman Z-Score of -272.53 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-272.53
Piotroski F-Score	2